Skip to content
10-Q

Quarterly Report

Metacrine, Inc.

0001564590-22-019874

← back to feed
Filed
May 12, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2022 · May 5, 2022 42.47M sh
Operating Cash Flow Q1 2022 · Mar 31, 2022 −$13.7M
Operating Cash Flow Q1 2022 · Mar 31, 2021 −$12.17M
Long Term Debt Q1 2022 · Mar 31, 2022 $13.43M
Long Term Debt Q1 2022 · Dec 31, 2021 $13.3M
Short Term Investments Q1 2022 · Mar 31, 2022 $29.65M
Short Term Investments Q1 2022 · Dec 31, 2021 $27.52M
Cash And Equivalents Q1 2022 · Mar 31, 2022 $33.04M
Cash And Equivalents Q1 2022 · Dec 31, 2021 $48.91M
Stockholders Equity Q1 2022 · Mar 31, 2022 $46.45M
Stockholders Equity Q1 2022 · Dec 31, 2021 $57.36M
Stockholders Equity Q1 2022 · Mar 31, 2021 $76.66M
Stockholders Equity Q1 2022 · Dec 31, 2020 $89.28M
Current Liabilities Q1 2022 · Mar 31, 2022 $5.47M
Current Liabilities Q1 2022 · Dec 31, 2021 $7.76M
Current Assets Q1 2022 · Mar 31, 2022 $66.74M
Current Assets Q1 2022 · Dec 31, 2021 $78.74M
Total Assets Q1 2022 · Mar 31, 2022 $66.74M
Total Assets Q1 2022 · Dec 31, 2021 $79.99M
Sga Expense Q1 2022 · Mar 31, 2022 $5.48M
Sga Expense Q1 2022 · Mar 31, 2021 $3.7M
Rd Expense Q1 2022 · Mar 31, 2022 $6.68M
Rd Expense Q1 2022 · Mar 31, 2021 $10.86M
Net Income Q1 2022 · Mar 31, 2022 −$12.88M
Net Income Q1 2022 · Mar 31, 2021 −$14.77M
Operating Income Q1 2022 · Mar 31, 2022 −$12.51M
Operating Income Q1 2022 · Mar 31, 2021 −$14.55M